10/13/2025Kelun-Biotech Presents Promising Phase 1 Data for CLDN18.2 ADC SKB315

10/13/2025Huadao Bio Secures Over CNY 100M in Series D+2 Financing

10/13/2025AviadoBio and UgeneX Enter Exclusive Option-License Deal to Develop Op...

10/13/2025China Introduces New Regulations to Govern Clinical Research and Appli...

10/13/2025CDE Issues Guidance to Address Common Challenges in Pediatric Drug Dev...

10/13/2025CDE Solicits Comments on Draft Guidelines for Bioequivalence Risk Asse...

10/13/2025CDE Seeks Input on Draft Technical Requirements for Sodium Iodide [131...

10/13/2025Two Decades of Pediatric Drug Trials in China Reveal Progress and Pers...

10/13/2025Lundbeck's Epilepsy Drug Bexicaserin Granted Breakthrough Therapy Stat...

10/13/2025Hansoh Pharma Reports Phase II Data for Oral B7H3 ADC HS-20093

10/13/2025Lepu Reports Early Clinical Data for ADC Programs in Various Cancers

10/13/2025Huadao Secures Over CNY 100M in Series D+2 Financing to Advance CAR-T ...

10/13/2025China's Innovative Drug Sector Secures Over CNY 4.2B in Q3 Financing, ...

10/13/2025U.S. Senate Approves Revised China Biotech Competition Bill with Softe...

10/13/2025First Drug Patent Term Extension Granted In China (Mondaq)

10/8/2025China Biopharma Financing Rebounds in September as IPO Pipeline Surges

10/8/2025License-Out Deals in China Drop Sharply in September Amid Steady Deal ...

10/8/2025Only Two Novel Drugs Win China Approval in September as Local Innovati...

10/3/2025Baidu-Backed Biotech Start-up Aims to Overtake AlphaFold in China's AI...

10/3/2025Medilink Initiates U.S. Phase 1/2 Trial for VEGF-Targeted ADC YL242

10/3/2025​​​​​​​BeOne and AbbVie Resolve Patent Dispute Over BTK Inhibit...

10/3/2025OncoC4 Raises $50M in Series B to Advance Next-Generation Cancer Thera...

10/3/2025Santen and RemeGen Files Chinese BLA for RC28-E

10/3/2025TJ Biopharma Secures CNY 600M to Advance Late-Stage Cancer and Rare D...

10/3/2025GRIT Biotech Raises CNY 380M in Series C Round

10/1/2025Binhui Biopharma Seeks Hong Kong Listing

10/1/2025CSPC Unit Accelerates Hong Kong Listing Amid China's Biotech Rally

10/1/2025China Rolls Out 2025 Pharmacopoeia to Sharpen Drug Oversight

10/1/2025Full-Life Tech Nets $77M to Propel Radiopharma Ambitions

9/30/2025Wuhan Binhui Biopharma Files for Hong Kong IPO

Page:16/809 Total number of articles:24243: [First][<<] [14] [15] [16] [17] [18] [>>] [End]